Page last updated: 2024-09-03

imatinib mesylate and Hypertriglyceridemia

imatinib mesylate has been researched along with Hypertriglyceridemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, X; Jiang, Q; Liu, J; Yu, L	1

Other Studies

1 other study(ies) available for imatinib mesylate and Hypertriglyceridemia

Article	Year
Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic myeloid leukaemia in the chronic phase. Scientific reports, 2019, 11-26, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cholesterol, LDL; Dasatinib; Female; Follow-Up Studies; Glucose; Humans; Hyperglycemia; Hypertriglyceridemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Lipid Metabolism; Male; Middle Aged; Neoplasm Proteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Salvage Therapy; Young Adult	2019

Article

Year

Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic myeloid leukaemia in the chronic phase.

Scientific reports, 2019, 11-26, Volume: 9, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cholesterol, LDL; Dasatinib; Female; Follow-Up Studies; Glucose; Humans; Hyperglycemia; Hypertriglyceridemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Lipid Metabolism; Male; Middle Aged; Neoplasm Proteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Salvage Therapy; Young Adult

2019